背景:已经报道了三氯膦钠和咪达唑仑用于小儿磁共振成像(MRI)的镇静成功率。然而,没有关于使用这些镇静剂的不良事件和检查成功率与患者医学背景相关的报告.我们进行这项研究来调查这些点。
方法:我们调查了2013年11月至2015年10月在松藤市医院接受三氯膦钠和咪达唑仑镇静MRI检查的191名儿科患者。我们调查了患者的特征,包括年龄,性别,体重,过敏,药物,神经肌肉,胃肠,呼吸,和心脏疾病,气道阻塞因素,和发育障碍。结果是镇静成功和不良事件,包括氧饱和度。我们回顾了患者背景与每个不良事件或镇静成功率之间的关系。
结果:在所有病例中,成功率为92.7%。年龄较大(赔率比[OR]=0.984),发育障碍(OR=0.215),和呼吸系统疾病(OR=0.353)是成功率较低的因素。添加咪达唑仑与更高的成功率相关(OR=5.971),但咪达唑仑总剂量较高与镇静失败相关(OR=0.003).唯一的不良事件是氧饱和度(11.5%)。年龄较大影响氧饱和度的多重分析。然而,通过逐步分析,没有患者的医疗背景或镇静剂量与氧饱和度相关。
结论:年龄较大,发育障碍,呼吸系统疾病与镇静衰竭相关。增加咪达唑仑并没有增加成功率,咪达唑仑可能有最佳剂量.
BACKGROUND: The success rate of sedation with triclofos sodium and midazolam for pediatric magnetic resonance imaging (MRI) has been reported. However, there are no reports of an association of adverse events and examination success rates with patient medical backgrounds using a combination of these sedatives. We performed this study to investigate these points.
METHODS: We investigated 191 pediatric patients who were sedated for MRI with triclofos sodium and midazolam at Matsudo City Hospital between November 2013 and October 2015. We surveyed the patients\' characteristics, including age, sex, body weight, allergies, medication, neuromuscular, gastrointestinal, respiratory, and cardiac disorders, airway obstruction factors, and developmental disorders. Outcomes were sedation success and adverse events, including oxygen desaturation. We reviewed the relationship between patient backgrounds and each adverse event or success rate of sedation.
RESULTS: Among all cases, the success rate was 92.7%. Older age (odds ratio [OR] = 0.984), developmental disorders (OR = 0.215), and respiratory disorders (OR = 0.353) were factors for lower success rates. Adding midazolam was associated with a higher success rate (OR = 5.971), but the higher total dose of midazolam was associated with sedation failure (OR = 0.003). The only adverse event was oxygen desaturation (11.5%). Older age affected oxygen desaturation with multiple analysis. However, by stepwise analysis, no patient medical background nor sedative dose was associated with oxygen desaturation.
CONCLUSIONS: Older age, developmental disorders, and respiratory disorders were associated with sedation failure. Increasing midazolam did not increase the success rate, and there might be an optimal dose of midazolam.